Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.96 USD | +0.20% | +1.64% | +14.55% |
Financials (USD)
Sales 2024 * | 231M | Sales 2025 * | 233M | Capitalization | 239M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 14M | EV / Sales 2024 * | 1.04 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.03 x |
P/E ratio 2024 * |
19.2
x | P/E ratio 2025 * |
29.3
x | Employees | 185 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology, Inc.
1 day | +0.20% | ||
1 week | +2.69% | ||
Current month | -2.17% | ||
1 month | -6.06% | ||
3 months | +1.43% | ||
6 months | +87.17% | ||
Current year | +14.55% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 18-11-04 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 18-02-22 |
Jay Moyes
BRD | Director/Board Member | 70 | 12-04-26 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 10-09-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 4.96 | +0.20% | 319,771 |
24-05-01 | 4.95 | -2.37% | 256,652 |
24-04-30 | 5.07 | +1.00% | 230,350 |
24-04-29 | 5.02 | 0.00% | 200,357 |
24-04-26 | 5.02 | +2.87% | 167,412 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.55% | 239M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- PBYI Stock